Lisa Olson
Chief Executive Officer chez Enthera Srl
Fortune : 26 760 $ au 31/03/2024
Profil
Lisa M.
Olson is currently the Chief Executive Officer at Enthera Srl, Director at Lassen Therapeutics 1, Inc., and an Assistant Professor at Washington University School of Law.
Previously, she was a Director at Enthera.
Srl, Vice President-Immunology Discovery at AbbVie Bioresearch Center, Inc., and the Chief Scientific Officer & Head-Research at Magenta Therapeutics, Inc. She received her undergraduate degree from Iowa State University and her doctorate from the University of Illinois At Urbana–Champaign.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2023 | 892 ( 0,00% ) | 26 760 $ | 31/03/2024 |
Postes actifs de Lisa Olson
| Sociétés | Poste | Début |
|---|---|---|
| Washington University School of Law | Corporate Officer/Principal | - |
Lassen Therapeutics 1, Inc.
 Lassen Therapeutics 1, Inc. Pharmaceuticals: MajorHealth Technology Lassen Therapeutics 1, Inc. develops pharmaceuticals. The company was founded by David King John and is headquartered in San Diego, CA. | Director/Board Member | 07/10/2021 |
Enthera Srl
 Enthera Srl BiotechnologyHealth Technology Enthera Srl develops therapeutic solutions to treat diabetes. The company was founded in 1985 by in October 2016 by Maria Gabriella Camboni, Paolo Fiorina and Francesca D'Addio and is headquartered in Milan, Italy. | Chief Executive Officer | 23/01/2024 |
Anciens postes connus de Lisa Olson
| Sociétés | Poste | Fin |
|---|---|---|
| MAGENTA THERAPEUTICS | Chief Tech/Sci/R&D Officer | 15/05/2023 |
Enthera Srl
Enthera Srl BiotechnologyHealth Technology Enthera Srl develops therapeutic solutions to treat diabetes. The company was founded in 1985 by in October 2016 by Maria Gabriella Camboni, Paolo Fiorina and Francesca D'Addio and is headquartered in Milan, Italy. | Director/Board Member | - |
| AbbVie Bioresearch Center, Inc. | Corporate Officer/Principal | - |
Formation de Lisa Olson
| Iowa State University | Undergraduate Degree |
| University of Illinois At Urbana–Champaign | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
| AbbVie Bioresearch Center, Inc. | |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Enthera Srl
Enthera Srl BiotechnologyHealth Technology Enthera Srl develops therapeutic solutions to treat diabetes. The company was founded in 1985 by in October 2016 by Maria Gabriella Camboni, Paolo Fiorina and Francesca D'Addio and is headquartered in Milan, Italy. | Health Technology |
Lassen Therapeutics 1, Inc.
Lassen Therapeutics 1, Inc. Pharmaceuticals: MajorHealth Technology Lassen Therapeutics 1, Inc. develops pharmaceuticals. The company was founded by David King John and is headquartered in San Diego, CA. | Health Technology |
